Scholarly Index
Eduard Gasal
Novartis (United States); 4,744 total citations; 65 total publications; best world rank #605
Novartis (United States)
4,744Total citations
65Total publications
23H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Melanoma and MAPK Pathways | 2021-2025 | 605 | US 206 | 75.97 |